Table 3

Visit/data collection measurement schedule

VariableAt enrolmentDuring follow-up in betweenAt delivery
Informed consentXPassive screening—2 weekly by a doctor or woman on demand
Inclusion/exclusion criteriaX
DemographicsX
Medical historyXXX
Physical examinationXX
MedicationsX
Full blood pictureX
ECG and ECHOX
Outcome events—MACO and FACEX
  • To be collected in all exposed women (with CVDs) and in a subset of unexposed women (without CVDs).

  • CVD, cardiovascular disease; ECHO, echocardiogram; FACE, fetal adverse clinical event; MACE, major adverse cardiac event.